NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury

Multiple sclerosis is a chronic inflammatory disease of the central nervous system, associated with demyelination and neurodegeneration. The mechanisms of tissue injury are poorly understood, but recent data suggest that mitochondrial injury may play an important role in this process. Mitochondrial injury can be triggered by reactive oxygen and nitric oxide species, and we recently provided evidence for oxidative damage of oligodendrocytes and dystrophic axons in early stages of active multiple sclerosis lesions. In this study, we identified potential sources of reactive oxygen and nitrogen species through gene expression in carefully staged and dissected lesion areas and by immunohistochemical analysis of protein expression. Genome-wide microarrays confirmed mitochondrial injury in active multiple sclerosis lesions, which may serve as an important source of reactive oxygen species. In addition, we found differences in the gene expression levels of various nicotinamide adenine dinucleotide phosphate oxidase subunits between initial multiple sclerosis lesions and control white matter. These results were confirmed at the protein level by means of immunohistochemistry, showing upregulation of the subunits gp91phox, p22phox, p47phox, nicotinamide adenine dinucleotide phosphate oxidase 1 and nicotinamide adenine dinucleotide phosphate oxidase organizer 1 in activated microglia in classical active as well as slowly expanding lesions. The subunits gp91phox and p22phox were constitutively expressed in microglia and were upregulated in the initial lesion. In contrast, p47phox, nicotinamide adenine dinucleotide phosphate oxidase 1 and nicotinamide adenine dinucleotide phosphate oxidase organizer 1 expression were more restricted to the zone of initial damage or to lesions from patients with acute or early relapsing/remitting multiple sclerosis. Double labelling showed co-expression of the nicotinamide adenine dinucleotide phosphate oxidase subunits in activated microglia and infiltrated macrophages, suggesting the assembly of functional complexes. Our data suggest that the inflammation-associated oxidative burst in activated microglia and macrophages plays an important role in demyelination and free radical-mediated tissue injury in the pathogenesis of multiple sclerosis.

[1]  H. Lassmann,et al.  Review: The architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis , 2011, Neuropathology and applied neurobiology.

[2]  H. Lassmann,et al.  The molecular basis of neurodegeneration in multiple sclerosis , 2011, FEBS letters.

[3]  F. Tchantchou,et al.  Arachidonyl trifluoromethyl ketone ameliorates experimental autoimmune encephalomyelitis via blocking peroxynitrite formation in mouse spinal cord white matter , 2011, Experimental Neurology.

[4]  Kenneth J. Smith.  Newly lesioned tissue in multiple sclerosis--a role for oxidative damage? , 2011, Brain : a journal of neurology.

[5]  Y. Zhang,et al.  Distinct role of nitric oxide and peroxynitrite in mediating oligodendrocyte toxicity in culture and in experimental autoimmune encephalomyelitis , 2011, Neuroscience.

[6]  H. Lassmann,et al.  Oxidative damage in multiple sclerosis lesions , 2011, Brain : a journal of neurology.

[7]  Mary T. Brinkoetter,et al.  A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis , 2011, Nature Medicine.

[8]  W. Brück,et al.  Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. , 2011, Brain : a journal of neurology.

[9]  Richard Reynolds,et al.  Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis , 2011, Annals of neurology.

[10]  H. D. de Vries,et al.  Radical changes in multiple sclerosis pathogenesis. , 2011, Biochimica et biophysica acta.

[11]  H. Lassmann,et al.  Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes , 2010, Glia.

[12]  H. D. de Vries,et al.  Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. , 2010, Free radical biology & medicine.

[13]  A. Vargas,et al.  Gene expression profiling of formalin‐fixed, paraffin‐embedded familial breast tumours using the whole genome‐DASL assay , 2010, The Journal of pathology.

[14]  Helga E de Vries,et al.  Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? , 2010, Mitochondrion.

[15]  K. Fujihara,et al.  Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination , 2010, Acta Neuropathologica.

[16]  P. Beart,et al.  Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. , 2010, Journal of Alzheimer's disease : JAD.

[17]  Z. Berente,et al.  Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death. , 2010, Brain : a journal of neurology.

[18]  J. Parratt,et al.  Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions , 2009, Annals of neurology.

[19]  J. Geurts,et al.  Enhanced number and activity of mitochondria in multiple sclerosis lesions , 2009, The Journal of pathology.

[20]  H. Lassmann,et al.  The cholinergic anti-inflammatory system limits T cell infiltration into the neurodegenerative CNS, but cannot counteract complex CNS inflammation , 2009, Neurobiology of Disease.

[21]  W. Brück,et al.  Molecular Changes in White Matter Adjacent to an Active Demyelinating Lesion in Early Multiple Sclerosis , 2009, Brain pathology.

[22]  Hans Lassmann,et al.  The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.

[23]  Peter K Stys,et al.  Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.

[24]  H. D. de Vries,et al.  Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. , 2008, Free radical biology & medicine.

[25]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[26]  D. Turnbull,et al.  Review: Mitochondria and disease progression in multiple sclerosis , 2008, Neuropathology and applied neurobiology.

[27]  H. D. de Vries,et al.  Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? , 2008, Free radical biology & medicine.

[28]  J. Mallet,et al.  Neurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase , 2008, The Journal of Neuroscience.

[29]  S. Love,et al.  Elevated myeloperoxidase activity in white matter in multiple sclerosis , 2008, Neuroscience Letters.

[30]  J. Timmer,et al.  Tremor-correlated neuronal activity in the subthalamic nucleus of Parkinsonian patients , 2008, Neuroscience Letters.

[31]  Ping Zhou,et al.  Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein , 2008, Proceedings of the National Academy of Sciences.

[32]  S. Love,et al.  Elevated Activity and Microglial Expression of Myeloperoxidase in Demyelinated Cerebral Cortex in Multiple Sclerosis , 2008, Brain pathology.

[33]  Silke von Ahlfen,et al.  Determinants of RNA Quality from FFPE Samples , 2007, PloS one.

[34]  H. D. Vries,et al.  Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology , 2007, Brain Research Reviews.

[35]  D. Willenborg,et al.  The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis , 2007, Journal of Neuroimmunology.

[36]  H. Lassmann,et al.  Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? , 2007, Brain : a journal of neurology.

[37]  C. Elger,et al.  Astrocytes are a specific immunological target in Rasmussen's encephalitis , 2007, Annals of neurology.

[38]  Hans Lassmann,et al.  The Immunopathology of Multiple Sclerosis: An Overview , 2007, Brain pathology.

[39]  H. Neumann,et al.  Suppression of Microglial Inflammatory Activity by Myelin Phagocytosis: Role of p47-PHOX-Mediated Generation of Reactive Oxygen Species , 2006, The Journal of Neuroscience.

[40]  H. Lassmann,et al.  Advanced Intercross Line Mapping of Eae5 Reveals Ncf-1 and CLDN4 as Candidate Genes for Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[41]  M. Esiri,et al.  Protein co-expression with axonal injury in multiple sclerosis plaques , 2006, Acta Neuropathologica.

[42]  R. Rudick,et al.  Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients , 2006, Annals of neurology.

[43]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[44]  O. Bizzozero,et al.  Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis , 2005, Journal of neuroscience research.

[45]  J. Volpe,et al.  Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Barnett,et al.  Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.

[47]  Bin Liu,et al.  Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  K. Hillan,et al.  Unlocking the archive – gene expression in paraffin‐embedded tissue , 2001, The Journal of pathology.

[49]  C. Brosnan,et al.  Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. , 2001, The American journal of pathology.

[50]  S. Croul,et al.  Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis , 2000, Journal of the Neurological Sciences.

[51]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[52]  Kenneth J. Smith,et al.  Demyelination: The Role of Reactive Oxygen and Nitrogen Species , 1999, Brain pathology.

[53]  H. Alder,et al.  Oxidative damage to DNA in plaques of MS brains , 1998, Multiple sclerosis.

[54]  R. Schmidt,et al.  Peroxynitrite formation within the central nervous system in active multiple sclerosis , 1998, Journal of Neuroimmunology.

[55]  K. Frei,et al.  Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis , 1998, European journal of immunology.

[56]  G. Murray,et al.  A highly sensitive detection method for immunohistochemistry using biotinylated tyramine , 1997, The Journal of pathology.

[57]  J M Land,et al.  Nitric Oxide‐Mediated Mitochondrial Damage in the Brain: Mechanisms and Implications for Neurodegenerative Diseases , 1997, Journal of neurochemistry.

[58]  J. Merrill,et al.  The role of nitric oxide in multiple sclerosis , 1997, Journal of Molecular Medicine.

[59]  S. Murphy,et al.  Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-kappaB binding to DNA. , 1997, The Biochemical journal.

[60]  O. Bagasra,et al.  Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Hans Lassmann,et al.  Monocyte/macrophage differentiation in early multiple sclerosis lesions , 1995, Annals of neurology.

[62]  H. Blum,et al.  A simple and rapid method for the detection of RNA in formalin-fixed, paraffin-embedded tissues by PCR amplification. , 1991, Biochemical and biophysical research communications.

[63]  A. Verhoeven,et al.  Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils. , 1989, Blood.

[64]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[65]  H. Lassmann,et al.  In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brain , 2004, Acta Neuropathologica.

[66]  S. Murphy.  Production of nitric oxide by glial cells: Regulation and potential roles in the CNS , 2000, Glia.

[67]  S. Murphy,et al.  Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF- j B binding to DNA , 1997 .